Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL20020433	门冬氨酸芦氟沙星	Rufloxacin Aspartate	Active ingredient	Chemical Drugs(4)	New Drug Application	2002-03-12	哈药集团制药总厂	Harbin Pharmaceutical Group Co Ltd GENERAL Pharm FACTORY	Certificate Issued	2004-01-14	view
CXL20020434	门冬氨酸芦氟沙星注射液	Rufloxacin Aspartate	Injection	Chemical Drugs(2)	New Drug Application	2002-03-12	哈药集团制药总厂	Harbin Pharmaceutical Group Co Ltd GENERAL Pharm FACTORY	Certificate Issued	2004-01-14	view